1. Home
  2. SXTP vs REVB Comparison

SXTP vs REVB Comparison

Compare SXTP & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

HOLD

Current Price

$0.49

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

N/A

Current Price

$4.28

Market Cap

1.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SXTP
REVB
Founded
2010
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.9M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
SXTP
REVB
Price
$0.49
$4.28
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$3.70
★ $124.25
AVG Volume (30 Days)
★ 321.8K
32.9K
Earning Date
11-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
36.77
★ 72.68
EPS
★ N/A
N/A
Revenue
★ $1,005,471.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$70.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 65.49
N/A
52 Week Low
$0.34
$0.44
52 Week High
$8.62
$4.75

Technical Indicators

Market Signals
Indicator
SXTP
REVB
Relative Strength Index (RSI) 29.77 58.73
Support Level N/A $0.97
Resistance Level $1.01 $4.06
Average True Range (ATR) 0.11 0.36
MACD -0.03 -0.07
Stochastic Oscillator 6.02 29.55

Price Performance

Historical Comparison
SXTP
REVB

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Share on Social Networks: